Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2007 Mar;51(3):819-25.
doi: 10.1128/AAC.00447-06. Epub 2006 Dec 4.

Randomized controlled comparison of ofloxacin, azithromycin, and an ofloxacin-azithromycin combination for treatment of multidrug-resistant and nalidixic acid-resistant typhoid fever

Affiliations
Randomized Controlled Trial

Randomized controlled comparison of ofloxacin, azithromycin, and an ofloxacin-azithromycin combination for treatment of multidrug-resistant and nalidixic acid-resistant typhoid fever

Christopher M Parry et al. Antimicrob Agents Chemother. 2007 Mar.

Abstract

Isolates of Salmonella enterica serovar Typhi that are multidrug resistant (MDR, resistant to chloramphenicol, ampicillin, and trimethoprim-sulfamethoxazole) and have reduced susceptibility to fluoroquinolones (nalidixic acid resistant, Na(r)) are common in Asia. The optimum treatment for infections caused by such isolates is not established. This study compared different antimicrobial regimens for the treatment of MDR/Na(r) typhoid fever. Vietnamese children and adults with uncomplicated typhoid fever were entered into an open randomized controlled trial. Ofloxacin (20 mg/kg of body weight/day for 7 days), azithromycin (10 mg/kg/day for 7 days), and ofloxacin (15 mg/kg/day for 7 days) combined with azithromycin (10 mg/kg/day for the first 3 days) were compared. Of the 241 enrolled patients, 187 were eligible for analysis (186 S. enterica serovar Typhi, 1 Salmonella enterica serovar Paratyphi A). Eighty-seven percent (163/187) of the patients were children; of the S. enterica serovar Typhi isolates, 88% (165/187) were MDR and 93% (173/187) were Na(r). The clinical cure rate was 64% (40/63) with ofloxacin, 76% (47/62) with ofloxacin-azithromycin, and 82% (51/62) with azithromycin (P = 0.053). The mean (95% confidence interval [CI]) fever clearance time for patients treated with azithromycin (5.8 days [5.1 to 6.5 days]) was shorter than that for patients treated with ofloxacin-azithromycin (7.1 days [6.2 to 8.1 days]) and ofloxacin (8.2 days [7.2 to 9.2 days]) (P < 0.001). Positive fecal carriage immediately posttreatment was detected in 19.4% (12/62) of patients treated with ofloxacin, 6.5% (4/62) of those treated with the combination, and 1.6% (1/62) of those treated with azithromycin (P = 0.006). Both antibiotics were well tolerated. Uncomplicated typhoid fever due to isolates of MDR S. enterica serovar Typhi with reduced susceptibility to fluoroquinolones (Na(r)) can be successfully treated with a 7-day course of azithromycin.

PubMed Disclaimer

Figures

FIG. 1.
FIG. 1.
Flow chart for recruitment of patients into the study.
FIG. 2.
FIG. 2.
Kaplan-Meier survival curve showing the percentage of patients still febrile following the start of treatment. The patients who failed treatment and required retreatment with a further course of antimicrobial are excluded. Oflox, ofloxacin; Azith, azithromycin.

Similar articles

Cited by

References

    1. Aarestrup, F. M., C. Wiuff, K. Mølbak, and E. J. Threlfall. 2003. Is it time to change fluoroquinolone breakpoints for Salmonella spp.? Antimicrob. Agents Chemother. 47:827-829. - PMC - PubMed
    1. Ackers, M.-L., N. D. Puhr, R. V. Tauxe, and E. D. Mintz. 2000. Laboratory-based surveillance of Salmonella serotype Typhi infections in the United States. JAMA 283:2668-2673. - PubMed
    1. Bethell, D. B., N. P. J. Day, M. D. Nguyen, C. McMullin, T. L. Ha, T. H. T. Dong, T. N. M. Le, T. M. L. Nguyen, Q. D. Nguyen, V. Ha, A. P. MacGowan, L. O. White, and N. J. White. 1996. Pharmacokinetics of oral and intravenous ofloxacin in children with multidrug-resistant typhoid fever. Antimicrob. Agents Chemother. 40:2167-2172. - PMC - PubMed
    1. Bethell, D. B., T. T. Hien, L. T. Phi, N. P. Day, H. Vinh, N. M. Duong, N. V. Len, L. V. Chuong, and N. J. White. 1996. Effects on growth of single short courses of fluoroquinolones. Arch. Dis. Child. 74:44-46. - PMC - PubMed
    1. Bhutta, Z. A., I. A. Khan, and M. Shadmani. 2000. Failure of short-course ceftriaxone chemotherapy for multidrug-resistant typhoid fever in children: a randomized controlled field trial in Pakistan. Antimicrob. Agents Chemother. 44:450-452. - PMC - PubMed

Publication types